Effects of Intensive Glucose Lowering in Type 2 Diabetes

By S. Schinner. 2009

3,474 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Physiology

View Paper: https://www.semanticscholar.org/paper/84d5d264256857ce013323ccc88fc9dadd46939c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Ralph DeFronzo
2. V. Basevi
3. John B. Buse
4. E. Ferrannini
5. Josephine M. Egan
6. Wook Kim
7. D. Nathan
8. M. Nauck

In Physiology

1. Ralph DeFronzo
2. J. Forbes
3. M. Ezzati
4. D. Nathan
5. Josephine M. Egan
6. M. Cooper
7. Wook Kim
8. Silvio E. Inzucchi

Citations in the corpus

• Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. (2015, neutral): “In other words, it is necessary to show a direct effect of dietary SFA on CVD.”
• The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis (2013, background): “For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
• Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2015, background): “Results from large trials have also suggested that overly aggressive control in older patients with more advanced disease may not have significant benefits and may indeed present some risk [6].”
• KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. (2012, result): “Moreover, there was an increase in allcause mortality among the intensively-treated group compared to the conventionally-treated group in the ACCORD study.(29) The reasons for this finding are uncertain, although further analysis showed that increased mortality was not directly attributable to hypog”
• The Role of Incretins in Glucose Homeostasis and Diabetes Treatment (2008, background): “1% of the intensively treated subjects with diabetes received exenatide (Gerstein et al., 2008).”
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2012, background): “In 2008, three shorter-term studies (Action to Control Cardiovascular Risk in Diabetes [ACCORD] [34], Action in Diabetes and Vascular Disease: Preterax and Diamicron”